Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article. IJRMCS 2024, 2 (02), 20-30. https://doi.org/10.70829/ijrmcs.v2.i2.0724002.